Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesOther bacterial diseasesICD-10-CM a31-infection-due-to-other-mycobacteria
    Ask Trek AI about this page

    ICD-10-CM Code For Infection Due To Other Mycobacteria: Group Overview

    The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group A31 includes infections caused by non-tuberculous mycobacteria such as Mycobacterium avium complex and other atypical mycobacterial species, covering pulmonary, cutaneous, lymphatic, and disseminated presentations. These ICD-10-CM diagnosis codes are used to document clinical scenarios including localized versus disseminated disease, specific organ involvement, and treatment-related complications, capturing disease severity, organ involvement, or clinical complexity relevant to this group. Accurate coding within the ICD-10-CM A31 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.

    Customize your policy alerts

    Sign up for ICD-10-CM Code For Infection Due To Other Mycobacteria: Group Overview policy alerts

    Get alerted when relevant policies change without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    ICD-10-CM A31: Infection Due To Other Mycobacteria Overview

    The ICD-10-CM A31 code group represents infections caused by non-tuberculous mycobacteria, affecting skin, soft tissue, lungs, lymph nodes, or disseminated systems. These infections target multiple body systems, often presenting with chronic localized or systemic disease. Accurate coding matters for appropriate reimbursement and to reflect clinical complexity for claims processing.

    Table of contents

    Progress1 / 6

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    When to Use

    Use codes from this group when a clinician documents infection due to non-tuberculous mycobacteria with specified anatomic site or disseminated disease. Select the most specific code available to reflect organism, site, and whether the infection is localized or disseminated for accurate clinical and billing records.

    ICD-10-CM Codes

    5 rows

    ICD-10-CM CodeDescription
    A31.0Pulmonary mycobacterial infection
    A31.1Cutaneous mycobacterial infection
    A31.2Disseminated mycobacterium avium-intracellulare complex (DMAC)
    A31.8Other mycobacterial infections
    A31.9Mycobacterial infection, unspecified

    DRG Codes

    11 rows

    DRG CodeDescription
    177Respiratory Infections and Inflammations with MCC
    178Respiratory Infections and Inflammations with CC
    179Respiratory Infections and Inflammations without CC/MCC
    606Minor Skin Disorders with MCC
    607Minor Skin Disorders without MCC
    867Other Infectious and Parasitic Diseases Diagnoses with MCC
    868Other Infectious and Parasitic Diseases Diagnoses with CC
    869Other Infectious and Parasitic Diseases Diagnoses without CC/MCC
    974HIV with Major Related Condition with MCC
    975HIV with Major Related Condition with CC
    976HIV with Major Related Condition without CC/MCC

    Typical Clinical Scenarios

    • An adult with progressive nodular skin lesions and draining sinuses after exposure to contaminated soil presents to dermatology with chronic, non-healing cutaneous nodules and subcutaneous abscesses. Tissue biopsy and culture grow nontuberculous mycobacteria species causing primary cutaneous infection, and the clinician assigns a code reflecting cutaneous mycobacterial infection. Typical codes: A31.0, A31.9
    • An elderly patient with long-standing bronchiectasis and chronic cough is admitted for worsening purulent sputum and systemic symptoms; respiratory cultures isolate Mycobacterium avium complex consistent with pulmonary mycobacterial disease. Because the infection involves the lower respiratory tract and requires targeted antimicrobial therapy, a pulmonary-specific mycobacterial infection code is assigned. Typical codes: A31.1, A31.9
    • A patient with human immunodeficiency virus (HIV) presents with disseminated fever, weight loss, hepatosplenomegaly, and positive blood cultures for atypical mycobacteria indicating disseminated infection as an opportunistic complication. Given multisystem involvement from non-tuberculous mycobacteria in an immunocompromised host, a disseminated mycobacterial infection code is used to capture the comorbidity and guide care coordination. Typical codes: A31.2, A31.9

    Related Codes

    A30-LEPROSY-HANSEN-S-DISEASE

    ICD-10-CM Code For Leprosy Hansen's Disease: Group Overview

    A32-LISTERIOSIS

    ICD-10-CM Code For Listeriosis: Group Overview

    A33-TETANUS-NEONATORUM

    ICD-10-CM Code For Tetanus Neonatorum: Group Overview

    A34-OBSTETRICAL-TETANUS

    ICD-10-CM Code For Obstetrical Tetanus: Group Overview

    A35-OTHER-TETANUS

    ICD-10-CM Code For Other Tetanus: Group Overview

    A36-DIPHTHERIA

    ICD-10-CM Code For Diphtheria: Group Overview

    A37-WHOOPING-COUGH

    ICD-10-CM Code For Whooping Cough: Group Overview

    A38-SCARLET-FEVER

    ICD-10-CM Code For Scarlet Fever: Group Overview

    A39-MENINGOCOCCAL-INFECTION

    ICD-10-CM Code For Meningococcal Infection: Group Overview

    A41-OTHER-SEPSIS

    ICD-10-CM Code For Other Sepsis: Group Overview

    Showing 1–10 of 16

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.